NASDAQ:AMRI Albany Molecular Research (AMRI) Stock Price, News & Analysis → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free AMRI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$21.74▼$21.7450-Day Range$21.74▼$21.7452-Week Range$13.01▼$22.17VolumeN/AAverage Volume872,120 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Albany Molecular Research alerts: Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About Albany Molecular Research Stock (NASDAQ:AMRI)Albany Molecular Research, Inc. is a contract research and manufacturing company. The Company operates through Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP) and Fine Chemicals (FC) segments. The DDS segment includes activities, such as drug lead discovery, optimization, drug development and small scale commercial manufacturing. The API segment includes pilot to commercial scale manufacturing of active pharmaceutical ingredients and intermediates. The DP segment includes pre-formulation, formulation and process development through commercial scale production of complex liquid-filled and lyophilized sterile injectable products and ophthalmic formulations. The FC segment includes lab to commercial scale synthesis of reagents and diverse compounds. It supplies a range of services and technologies supporting the discovery and development of pharmaceutical products, the manufacturing of API and drug product for new and generic drugs.Read More Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. AMRI Stock News HeadlinesApril 9, 2024 | finance.yahoo.comDenovo Biopharma Announces a Major Breakthrough in Treatment‑Resistant Depression with Precision MedicineApril 3, 2024 | finance.yahoo.comDenovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision MedicineApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...February 29, 2024 | msn.comCops who allegedly abducted Amri also involved in Pastor Koh’s disappearance, court toldFebruary 26, 2024 | msn.comGovt withdraws appeal over production of report on activist’s disappearanceFebruary 21, 2024 | finance.yahoo.comWilliam S. Marth Joins CONTINUUS Pharmaceuticals Board of Directors, Bringing Commercial Leadership and Manufacturing Expertise to the CompanyJanuary 31, 2024 | bizjournals.comWho and what you missed at the Elevate Albany: State of the Region SummitJanuary 23, 2024 | bizjournals.comCuria Global puts Albany headquarters building up for saleApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...November 18, 2023 | msn.comSuri has experimented with a different approach in 'Bad Manners'November 15, 2023 | bizjournals.comUAlbany, IBM announce new $20 million AI research collaborationNovember 15, 2023 | finance.yahoo.comIn Silico Drug Discovery Market Size Worth USD 11.68 Billion in 2032 | Emergen ResearchNovember 8, 2023 | benzinga.comGlobal Small Molecule API Market to Reach US$ 174 Billion by 2033, Registering a CAGR of 4.1% | Future Market Insights, Inc.November 5, 2023 | msn.comBrain dead woman’s organs to save 6 lives in OdishaSeptember 30, 2023 | msn.comMubadala, BIA eye Manipal Hospitals stakeSeptember 22, 2023 | msn.comManipal Hospitals acquires 84% stake in AMRI Hospitals to ramp up presence in Eastern IndiaSeptember 21, 2023 | msn.comConsolidation in India healthcare continues with Manipal acquiring majority stake in AMRI hospitalsSeptember 13, 2023 | finance.yahoo.comCuria Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA VaccineJuly 3, 2023 | forbes.comAlbany, GAJune 29, 2023 | finanznachrichten.deCuria Global, Inc.: Curia wins 2023 Frost & Sullivan Customer Value Leadership AwardJune 28, 2023 | health.usnews.comBest Hospitals in Albany, NYJune 20, 2023 | finance.yahoo.comGlobal Drug Discovery Outsourcing Market to 2030: Players Include Merck & Co, Thermos Fisher Scientific, Dalton Pharma Services and OncodesignJune 14, 2023 | finance.yahoo.comVaccine Contract Manufacturing Global Market Report 2023: Sector to Reach $7 Billion by 2030 at a 3.9% CAGRJune 11, 2023 | msn.comWhat is govt hiding in Amri case, say rights groupsJune 10, 2023 | msn.comGovt to study task force’s classified report on Amri’s disappearanceJune 1, 2023 | benzinga.comGlobal Drug Discovery Services Market Report 2023: Rising Focus on Drug Discovery Trials Bolsters GrowthMay 16, 2023 | bizjournals.comAlbany has two star biotech companies. This company sees room for more.See More Headlines Receive AMRI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Albany Molecular Research and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2016Today4/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:AMRI CUSIPN/A CIK1065087 Webwww.amriglobal.com Phone+1-518-4640279FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesWilliam S. MarthPresident, Chief Executive Officer, DirectorFelicia LadinChief Financial Officer, Senior Vice President, TreasurerLori M. Henderson Esq.Senior Vice President, General Counsel, SecretaryChristopher M ConwaySenior Vice President - Discovery and Development and Global Commercial SalesBio & Compensation - Milton BoyerSenior Vice President - Drug Product ManufacturingBio & Compensation - Steven R. Hagen Ph.D.Senior Vice President - Manufacturing and PharmaceuticalsGeorge SvokosChief Commercial Officer and Senior Vice President, APIJimmy Wang Ph.D.Chief Information OfficerBio & Compensation - Thomas E. D' Ambra Ph.D.Non-Executive Chairman of the BoardDavid H. DemingDirectorMore Executives AMRI Stock Analysis - Frequently Asked Questions How were Albany Molecular Research's earnings last quarter? Albany Molecular Research Inc (NASDAQ:AMRI) posted its earnings results on Tuesday, May, 10th. The biotechnology company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.14. The biotechnology company earned $102.80 million during the quarter, compared to analysts' expectations of $107.20 million. What other stocks do shareholders of Albany Molecular Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other Albany Molecular Research investors own include Casella Waste Systems (CWST), Zevra Therapeutics (KMPH), Teva Pharmaceutical Industries (TEVA), Allergan (AGN), INSYS Therapeutics (insy), Taro Pharmaceutical Industries (TARO), Altaba (AABA), Analog Devices (ADI), Abbott Laboratories (ABT) and Alkermes (ALKS). This page (NASDAQ:AMRI) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Albany Molecular Research Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
